These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3121396)

  • 1. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation.
    Horvath PM; Styler M; Hammond JM; Shelden RM; Kemmann E
    Fertil Steril; 1988 Jan; 49(1):159-62. PubMed ID: 3121396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.
    Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
    Fertil Steril; 1988 Jan; 49(1):90-5. PubMed ID: 3121401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer.
    Sathanandan M; Warnes GM; Kirby CA; Petrucco OM; Matthews CD
    Fertil Steril; 1989 Jun; 51(6):998-1006. PubMed ID: 2498135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin and estradiol levels during ovarian stimulation in women treated with leuprolide acetate.
    Stone BA; Serafini PC; Quinn K; Quinn P; Kerin JF; Marrs RP
    Obstet Gynecol; 1989 Jun; 73(6):990-5. PubMed ID: 2498795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program.
    Chang YS; Kim SH; Shin CJ; Kim JG; Moon SY; Lee JY
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):337-45. PubMed ID: 2129188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
    Brzyski RG; Jones GS; Jones HW; Oehninger S; Muasher SJ
    Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.
    Scott RT; Navot D
    Fertil Steril; 1994 May; 61(5):880-5. PubMed ID: 8174725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of steroid and protein hormones in antral fluids of women treated with different combinations of gonadotropins, clomiphene citrate, and a gonadotropin-releasing hormone analog.
    Stone BA; Vargyas JM; Marrs RP; Quinn PJ; Batzofin JH; Tan T; Kerin JF; Serafini PC
    Fertil Steril; 1988 Feb; 49(2):249-57. PubMed ID: 3123276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.
    Cummins JM; Yovich JM; Edirisinghe WR; Yovich JL
    J In Vitro Fert Embryo Transf; 1989 Dec; 6(6):345-52. PubMed ID: 2517507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
    Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
    Gelety TJ; Surrey ES
    J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval.
    Cedars MI; Surey E; Hamilton F; Lapolt P; Meldrum DR
    Fertil Steril; 1990 Apr; 53(4):627-31. PubMed ID: 2108057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
    Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
    Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
    Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
    Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment.
    Radwanska E; Rawlins RG; Tummon I; Maclin V; Binor Z; Dmowski WP
    Fertil Steril; 1988 Feb; 49(2):356-9. PubMed ID: 3123281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.